Skip to content

Short-term effects of black tea on vascular function in healthy adults

Short-term effects of black tea on vascular function in healthy adults

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12617000302358
Enrollment
17
Registered
2017-02-27
Start date
2017-03-02
Completion date
2017-03-31
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Population studies indicate that regular consumption of tea can reduce the risk of cardiovascular disease by between 5 and 15%. The pooled estimate of risk reduction for black tea is influenced by two studies which included populations from the United Kingdom where milk is traditionally added to tea. This has led to the suggestion that addition of milk may diminish or negate cardiovascular health benefits of tea. Results of population and intervention studies suggest that regular consumption of tea can reduce blood pressure by 1 to 10 mm Hg. At a population level, a 5 mm Hg lower blood pressure would be associated with a 10% lower risk of coronary artery disease, and a 20% lower risk of stroke. A meta-analysis of randomised controlled trials to have assessed the effects of tea on endothelial function was recently published. This analysis suggests that acute and chronic tea ingestion can improve endothelial function, assessed by measuring flow-mediated dilatation of the brachial artery, by 30 to 40% (~2% absolute improvement). If sustained, this would be associated with about a 25% reduction in risk of cardiovascular events, which would be consistent with estimates of risk reduction from population studies. The precise pathway linking flavonoids to vascular function is not clear. However, it is known that the majority of dietary flavonoids are not absorbed or bioactive without prior metabolism by specific groups of enzymes produced by the microbes residing in the gastrointestinal tract (the microbiome). Although increased flavonoid intake can improve measures of vascular function, there is substantial inter-individual variability in response. Current knowledge of flavonoid metabolism indicates that this is largely due to individual differences in the capacity of the microbiome to metabolise flavonoids. However, this hypothesis has yet to be explored. Initial research needs to describe changes to the microbiome that occur with tea consumption. Furthermore, despite studies showing that the effect of the addition of milk to tea on bioavailability of tea flavonoids is modest, questions remain regarding the effects of milk to black tea on its bioactivity. One study has suggested that addition of milk almost negates the acute improvement in endothelial function. However, it is possible that this may relate to the study design, where endothelial function was assessed at a single time point following a single dose of tea. It is possible that addition of milk may delay absorption of the active components of tea (the flavonoids), but the overall impact on endothelial function is similar. Thus, the primary aim of the proposed study will be to investigate the short-term effects of black tea on endothelial function. We will investigate the effect of the addition of milk to black tea on its bioactivity. We will also describe and compare the changes to the microbiome after short-term regular consumption of black tea with and without milk.

Interventions

15 healthy men and women 18 to 75 years old will be recruited from the general population. Volunteers will have no history of major chronic disease. A randomised, controlled, cross-over designed trial will be performed. Each participant will complete 3 visits in random order. Prior to each visit participants will be asked to consume a standard meal for dinner (the night before their visit) and a low-fat breakfast (on the morning of their visit). Prior to the first visit, participants will be as

15 healthy men and women 18 to 75 years old will be recruited from the general population. Volunteers will have no history of major chronic disease. A randomised, controlled, cross-over designed trial will be performed. Each participant will complete 3 visits in random order. Prior to each visit participants will be asked to consume a standard meal for dinner (the night before their visit) and a low-fat breakfast (on the morning of their visit). Prior to the first visit, participants will be asked to document the meals so that they are able to repeat them for subsequent visits. For each visit participants will attend the School of Medicine and Pharmacology Research Unit at Royal Perth Hospital in the morning 2.5 hours after breakfast. Participants will consume for 28 days, 3 cups per day (morning, during the day and afternoon/evening), of the following beverages: 1. Hot water (200 ml) 2. Black tea (2 g tea leaves infused in 200 ml) 3. Black tea with added milk (2 g tea leaves infused in 200 ml plus 20 ml of low fat [1.5%] milk) The order of beverage consumption will be randomly assigned. There will be no washout between periods. On the morning of each visit, participants consume 1 cup of their assigned beverage with their breakfast meal, then a second cup 1.5 hours later. One hour after this they will attend the clinic for assessments of outcomes. All teas will be matched for total polyphenol content. Adherence will be monitored using participant diaries, tea bag counts and measurement of biomarkers of tea-derived flavonoid exposure in urine.

Sponsors

Jonathan Hodgson
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

men and women Aged 18 to 75 years old No history of major chronic disease.

Exclusion criteria

1 current or recent (<12 months) smoking 2 body mass index < 18 or > 35 kg/m2, 3 history of cardiovascular or peripheral vascular disease, 4 diagnosed diabetes, and non-diabetic individuals with fasting plasma glucose concentrations greater than or equal to 6.5 mmol/L, 5 a psychiatric illness, or other major illnesses such as cancer, 6 current or recent (within previous 6 months) significant weight loss or gain (> 6% of body weight), 7 alcohol intake > 210 g per wk for women and > 280 g per wk for men, 8 inability or unwillingness to follow the study protocol.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026